Rainier Therapeutics
Latest round
- Series B
Last raised
- May 2018
Total raised
- $79M
Investors
- 7
About Rainier Therapeutics
Rainier Therapeutics, Inc.Rainier Therapeutics, Inc. operates in San Leandro, US, and was founded in 2010. The company specializes in creating biopharmaceutical products aimed at unmet medical needs. In July 2021, Fusion Pharmaceuticals Inc. acquired Rainier Therapeutics, Inc. for undisclosed financial terms.BioClin Therapeutics specializes in developing innovative biopharmaceutical products aimed at addressing unmet medical needs in the therapeutic arena. Their core offerings include a range of biologic treatments tailored for various chronic conditions, focusing on enhancing patient outcomes through targeted therapies. These products leverage advanced biotechnology methodologies to facilitate precise action within the human body, ultimately improving disease management. With a clientele that spans hospitals, healthcare providers, and research institutions, the company aims to cater to both domestic and international markets, specifically targeting regions such as North America and Europe.The revenue structure of BioClin Therapeutics is primarily driven by direct sales to healthcare institutions and partnerships with pharmaceutical distributors. Transactions typically occur through a B2B model, where healthcare facilities and research organizations acquire the company's products as part of their treatment protocols. Flagship products may be offered under subscription models or bulk procurement agreements, facilitating consistent revenue streams.00 mn to support the development of new biopharmaceutical products aimed at chronic conditions. The company is looking to expand its market presence in North America and Europe by 2024, with strategic initiatives to enhance its distribution networks. Recent acquisitions and partnerships will play a crucial role in facilitating entry into these markets.
Who invested in Rainier Therapeutics
7 investors across 4 rounds
See all investors in Rainier Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rainier Therapeutics
Who invested in Rainier Therapeutics?
Rainier Therapeutics has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rainier Therapeutics raised?
Rainier Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Rainier Therapeutics last raise money?
Rainier Therapeutics's most recent round on record is a Series B, in May 2018.
What does Rainier Therapeutics do?
Rainier Therapeutics is a biotechnology company.
Where is Rainier Therapeutics headquartered?
Rainier Therapeutics is headquartered in San Leandro, US.
Which VCs invest in companies like Rainier Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Rainier Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Rainier Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.